Abstract 19637: Two Decades of Cardiovascular Trials With Primary Surrogate Endpoints: 1990- 2011

作者
Behnood Bikdeli,Natdanai Punnanithinont,Yasir Akram,Ike Lee,Nihar R. Desai,Joseph S. Ross,Harlan M. Krumholz
出处
期刊:Circulation [Lippincott Williams & Wilkins]
卷期号:132 (suppl_3)
标识
DOI:10.1161/circ.132.suppl_3.19637
摘要

Background: Surrogate endpoint trials can test strategies more efficiently, but are accompanied by uncertainty about the relationship between changes in surrogate markers and clinical outcomes. We sought to determine recent trends in the publication of cardiovascular trials with surrogate outcomes. Methods: We identified cardiovascular trials with primary surrogate endpoints published in NEJM, Lancet, and JAMA from January 1990 to December 2011. Trends in publication of surrogate endpoint trials, and the success of the trials in meeting their primary endpoint were evaluated. We also tracked the above three journals for publication of clinical outcome trials on the interventions tested in surrogate trials. Results: We screened 3016 articles and identified 848 primary hypothesis cardiovascular trials, which included 220 surrogate endpoint trials. There was an increase over time in the number of surrogate endpoint trials (P=0.01). From the total of 220 surrogate trials, 157 (71.4 %) were positive for their primary endpoint. Sixty (27.5%) surrogate trials were followed by at least one clinical outcome trial. Among these 60 surrogate trials, in 24 cases the outcomes trial results validated the positive surrogates; whereas in 21 subsequent outcome trials were negative following positive results on a surrogate. However, we identified only 3 examples in which the surrogate trial was negative but a subsequent outcomes trial was conducted and showed benefit (Figure). Conclusions: Cardiovascular surrogate outcomes trials are common, frequently show superiority of the tested intervention and are infrequently followed by a prominent outcomes trial. However, when there was a high profile clinical outcomes study, half of the positive surrogate trials were not validated. Cardiovascular surrogate outcome trials may be more appropriate for excluding benefit from the patient perspective than for identifying it.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
开心枣枣完成签到 ,获得积分10
刚刚
1秒前
3秒前
科目三的应助被MiyaGuo采纳,获得10
3秒前
哈妮s完成签到,获得积分10
3秒前
Dreamer发布了新的文献求助10
3秒前
科研通AI6.2的应助被Frank采纳,获得10
3秒前
热情松鼠完成签到,获得积分20
4秒前
5秒前
辛勤怜寒完成签到 ,获得积分10
6秒前
hzzzzz发布了新的文献求助10
6秒前
7秒前
友好的冰巧完成签到,获得积分10
8秒前
8秒前
lmy的应助被xxdwyd采纳,获得10
9秒前
科研通AI6.3的应助被tlc_191026采纳,获得10
9秒前
xx发布了新的文献求助10
9秒前
9秒前
9秒前
10秒前
10秒前
10秒前
11秒前
坦率恶天完成签到,获得积分10
12秒前
111发布了新的文献求助10
12秒前
ding的应助被六六大顺采纳,获得10
12秒前
Olive发布了新的文献求助10
13秒前
14秒前
郑睿涛发布了新的文献求助10
14秒前
14秒前
14秒前
15秒前
15秒前
科研通AI2S的应助被牧百川采纳,获得10
15秒前
科小研发布了新的文献求助10
15秒前
15秒前
冷冷子发布了新的文献求助10
16秒前
热情松鼠发布了新的文献求助10
16秒前
yzh发布了新的文献求助30
17秒前
无极微光的应助被曲昊采纳,获得20
18秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Improving the wear resistance of vehicle gear oil by oil soluble LaF3 nanoparticles and typical additives of gear oil 500
Boundaries and Bodhisattvas 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8183508
求助须知:如何正确求助?哪些是违规求助? 9572862
关于积分的说明 21827639
捐赠科研通 7780681
什么是DOI,文献DOI怎么找? 3434016
关于科研通互助平台的介绍 2558189
邀请新用户注册赠送积分活动 2480405